Tyra Biosciences, Inc.
NASDAQ:TYRA
16.42 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 58.006 | 251.213 | 302.182 | 15.224 | 0.108 |
| Short Term Investments
| 145.463 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 203.469 | 251.213 | 302.182 | 15.224 | 0.108 |
| Net Receivables
| 0.7 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 7.502 | 6.075 | 1.875 | 0.057 | 0.019 |
| Total Current Assets
| 211.671 | 257.288 | 304.057 | 15.281 | 0.127 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 8.154 | 3.543 | 2.089 | 0.466 | 0.276 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | -0.505 | 0 | 0 |
| Long Term Investments
| 1 | 1 | 0.243 | 0.243 | 0 |
| Tax Assets
| 0 | 0 | 0.262 | 0 | 0 |
| Other Non-Current Assets
| 5.032 | 4.35 | 0.555 | 0.021 | 0.125 |
| Total Non-Current Assets
| 14.186 | 8.893 | 2.644 | 0.73 | 0.401 |
| Total Assets
| 225.857 | 266.181 | 306.701 | 16.011 | 0.528 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 4.662 | 1.145 | 0.599 | 0.664 | 0.327 |
| Short Term Debt
| 0.28 | 0.14 | 0.202 | 0.142 | 0.139 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0.364 |
| Other Current Liabilities
| 10.391 | 4.416 | 2.815 | 1.052 | 4.325 |
| Total Current Liabilities
| 15.333 | 5.701 | 3.616 | 1.858 | 5.155 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 6.216 | 2.482 | 0.981 | 27.651 | 0.114 |
| Deferred Revenue Non-Current
| 0 | 0 | -0.262 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.262 | 0 | 0 |
| Other Non-Current Liabilities
| 0.046 | 0.169 | 0.367 | 0.14 | 0 |
| Total Non-Current Liabilities
| 6.262 | 2.651 | 1.348 | 27.791 | 0.114 |
| Total Liabilities
| 21.595 | 8.352 | 4.964 | 29.649 | 5.269 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 306.701 | 0.028 | 0 |
| Common Stock
| 0.004 | 0.004 | 0.004 | 0 | 0 |
| Retained Earnings
| -164.83 | -95.696 | -40.371 | -14.077 | -4.741 |
| Accumulated Other Comprehensive Income/Loss
| 0.381 | -0 | -306.701 | 0 | 0 |
| Other Total Stockholders Equity
| 368.707 | -0.004 | 342.104 | 0.411 | 0 |
| Total Shareholders Equity
| 204.262 | -95.696 | 301.737 | -13.638 | -4.741 |
| Total Equity
| 204.262 | -95.696 | 301.737 | -13.638 | -4.741 |
| Total Liabilities & Shareholders Equity
| 225.857 | -87.344 | 306.701 | 16.011 | 0.528 |